rhinitis%20-%20allergic
RHINITIS - ALLERGIC
Allergic rhinitis is a symptomatic disorder of the nose secondary to IgE-mediated inflammation of the nasal membranes induced after exposure to allergens.
Major symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Other symptoms include headache, conjunctival symptoms, eye pruritus, impaired smell and morning cough.
Symptoms can reverse spontaneous w/ or w/o treatment.

Definition

Rhinitis

  • Inflammation of the nasal lining membranes

 Allergic Rhinitis

  • A symptomatic disorder of the nose secondary to IgE-mediated inflammation of the nasal membranes induced after exposure to allergens

Signs and Symptoms

Major symptoms

  • Nasal itching
  • Watery rhinorrhea
  • Nasal obstruction/congestion
  • Sneezing
  • Postnasal drainage

Other symptoms

  • Headache
  • Conjunctival symptoms, eye pruritus
  • Impaired smell
  • Morning cough
  • Sleep problems/excessive daytime sleepiness/sleep-disordered breathing or obstructive sleep apnea

Symptoms can reverse spontaneously with or without treatment

Pathophysiology

  • There may be various diatheses for allergic rhinitis sensitization but the most important mechanisms are:
    • Genetic factors 
    • Production of IgE antibody 
  • Most allergic rhinitis are caused by inhalation antigens such as:
    • Dermatophagoides (antigen in house dust) - most common
    • Pollens (eg trees, grasses and weeds) - most common
    • Fungi
    • Pets
  • Two phase reactions:
    • Early phase reaction happens when histamine and leukotrienes are released from mast cells and irritates the sensory nerve endings and blood vessels of the nasal mucosa
      • This irritation causes sneezing, rhinorrhea (watery), nasal mucosal swelling or blockage 
    • Late phase reaction happens when inflammatory cells like activated eosinophils infiltrate the nasal mucosa that are exposed to these antigens
      • Seen 6-10 hours after the exposure to antigens
      • Causes mucosal swelling
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 30 Apr 2019
A shorter regimen comprising a seven-drug cocktail which included high-dose moxifloxacin for 9 months was noninferior to the WHO*-recommended long regimen of 20 months for treating rifampicin-resistant tuberculosis (TB), according to the STREAM** study, providing a feasible and lower-cost treatment option in resource-poor setting.
31 Jan 2017
New drug applications approved by US FDA as of 16 - 31 January 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.